News for TOI Stock

The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1 The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 The Oncology Institute Announces $16.5 million Private Placement The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown Florida Blue enhances cancer care for thousands of members The Oncology Institute Reports Third Quarter 2024 Financial Results The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care The Oncology Institute of Hope & Innovation Launches Oregon Market The Oncology Institute Announces CFO Transition The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call The Oncology Institute to Participate at Upcoming Investor Conferences The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024 MaxHealth & The Oncology Institute Expand Value-Based Care Partnership The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call The Oncology Institute to Participate at Upcoming Investor Conferences Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call The Oncology Institute Names Jeremy Castle as Chief Operations Officer The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit The Oncology Institute Regains Compliance with Nasdaq Listing Requirements Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research The Oncology Institute to Open Project Southland The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting The Oncology Institute to Participate at Upcoming Investor Conferences The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer The Oncology Institute Announces First Quarter 2023 Earnings Release Date and Conference Call CORRECTION -- The Oncology Institute Reports Updated Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023 The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023 The Oncology Institute to Participate at Upcoming Investor Conferences The Oncology Institute Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call The Oncology Institute Expands Into Chino, CA The Oncology Institute Rebrands Clinical Trials Division The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call The Oncology Institute Executives to Speak at Key Industry Conferences in Q4 The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials The Oncology Institute Expands into South Florida The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib The Oncology Institute Appoints Two New Board Members The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium The Oncology Institute Becomes Certified as a Patient Safety Organization The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day The Oncology Institute Reports Second Quarter 2022 Financial Results and Reaffirms Full Year 2022 Guidance The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets The Oncology Institute Continues its Nevada Expansion The Oncology Institute Announces Second Quarter 2022 Earnings Release Date and Conference Call The Oncology Institute Continues Southern California Expansion The Oncology Institute Announces Expanded Strategic Agreement with McKesson for Distribution of Pharmaceuticals The Oncology Institute to Participate at the Cowen Virtual FutureHealth Conference The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes The Oncology Institute Announces Opening of Austin’s Newest Innovative Cancer Clinics The Oncology Institute to Participate at Upcoming Investor Conferences The Oncology Institute Reports First Quarter 2022 Financial Results and Confirms Full Year 2022 Guidance The Oncology Institute of Hope & Innovation Adds Fresno Practice to Network The Oncology Institute Announces First Quarter 2022 Earnings Release Date and Conference Call The Oncology Institute Reaches $9.5M Total Saved to Medicare While Exceeding Quality Benchmarks The Oncology Institute Names Mihir Shah as Chief Financial Officer The Oncology Institute Adds New Culver City Clinic and Expands Riverside Location The Oncology Institute Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Strong Growth Outlook for 2022 The Oncology Institute to Participate at the Jefferies Value-Based Healthcare Summit The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller UPDATE - The Oncology Institute Enters Into Value-Based Agreement with MaxHealth The Oncology Institute Enters Into Value-Based Agreement with MaxHeath The Oncology Institute Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call The Oncology Institute Expands Florida Presence with Lakeland Clinic, Physician Dispensary UPDATE - The Oncology Institute of Hope & Innovation Celebrates 50th Practice Location UPDATE - The Oncology Institute of Hope & Innovation Adds Los Angeles Practices to Network UPDATE - The Oncology Institute Completes Business Combination with DFP Healthcare Acquisitions Corp. to Become Publicly-Traded Company The Oncology Institute Adds San Gabriel Valley Practices to Network The Oncology Institute Completes Business Combination with DFP Healthcare Acquisitions Corp. to Become Publicly-Traded Company